Figure 1.
Target attainment of trimethoprim for infections with Pneumocystis jirovecii pneumonia for different dosing regimens and different eGFRs. Low is determined as a C max below 5 mg/L, toxic is determined as a C max above 15 mg/L.
Target attainment of trimethoprim for infections with Pneumocystis jirovecii pneumonia for different dosing regimens and different eGFRs. Low is determined as a C max below 5 mg/L, toxic is determined as a C max above 15 mg/L.